| Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization J Shi, J Zhou, VB Shah, C Aiken, K Whitby Journal of virology 85 (1), 542-549, 2011 | 263 | 2011 |
| The host proteins transportin SR2/TNPO3 and cyclophilin A exert opposing effects on HIV-1 uncoating VB Shah, J Shi, DR Hout, I Oztop, L Krishnan, J Ahn, MS Shotwell, ... Journal of virology 87 (1), 422-432, 2013 | 162 | 2013 |
| Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes L Lamorte, S Titolo, CT Lemke, N Goudreau, JF Mercier, E Wardrop, ... Antimicrobial agents and chemotherapy 57 (10), 4622-4631, 2013 | 127 | 2013 |
| β-glucan activates microglia without inducing cytokine production in dectin-1-dependent manner VB Shah, Y Huang, R Keshwara, T Ozment-Skelton, DL Williams, ... The Journal of Immunology 180 (5), 2777-2785, 2008 | 110 | 2008 |
| Kinetics of HIV-1 capsid uncoating revealed by single-molecule analysis CL Marquez, D Lau, J Walsh, V Shah, C McGuinness, A Wong, ... Elife 7, e34772, 2018 | 104 | 2018 |
| Rhesus TRIM5α disrupts the HIV-1 capsid at the interhexamer interfaces G Zhao, D Ke, T Vu, J Ahn, VB Shah, R Yang, C Aiken, LM Charlton, ... PLoS pathogens 7 (3), e1002009, 2011 | 102 | 2011 |
| β-Glucan attenuates TLR2-and TLR4-mediated cytokine production by microglia VB Shah, DL Williams, L Keshvara Neuroscience letters 458 (3), 111-115, 2009 | 66 | 2009 |
| In vitro uncoating of HIV-1 cores VB Shah, C Aiken JoVE (Journal of Visualized Experiments), e3384, 2011 | 62 | 2011 |
| Vav1 and PI3K are required for phagocytosis of β-glucan and subsequent superoxide generation by microglia VB Shah, TR Ozment-Skelton, DL Williams, L Keshvara Molecular immunology 46 (8-9), 1845-1853, 2009 | 50 | 2009 |
| Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor J Shi, J Zhou, UD Halambage, VB Shah, MJ Burse, H Wu, WS Blair, ... Journal of virology 89 (1), 208-219, 2015 | 37 | 2015 |
| Signaling through Disabled 1 requires phosphoinositide binding Y Huang, V Shah, T Liu, L Keshvara Biochemical and biophysical research communications 331 (4), 1460-1468, 2005 | 29 | 2005 |
| Fluorescence biosensor for real-time interaction dynamics of host proteins with HIV-1 capsid tubes D Lau, JC Walsh, W Peng, VB Shah, S Turville, DA Jacques, T Böcking ACS applied materials & interfaces 11 (38), 34586-34594, 2019 | 20 | 2019 |
| INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo S Mathew, M Nguyen, X Wu, A Pal, VB Shah, VR Prasad, C Aiken, ... Retrovirology 10, 1-20, 2013 | 20 | 2013 |
| Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells T Liu, RA Schneider, V Shah, Y Huang, RI Likhotvorik, L Keshvara, ... Journal of Inflammation 6, 1-9, 2009 | 18 | 2009 |
| Self-assembly of fluorescent HIV capsid spheres for detection of capsid binders D Lau, JC Walsh, A Mousapasandi, N Ariotti, VB Shah, S Turville, ... Langmuir 36 (13), 3624-3632, 2020 | 15 | 2020 |
| HIV nuclear entry: clearing the fog VB Shah, C Aiken Viruses 2 (5), 1190-1194, 2010 | 10 | 2010 |
| Rapid HIV-1 capsid interaction screening using fluorescence fluctuation spectroscopy D Lau, JC Walsh, CF Dickson, A Tuckwell, JH Stear, DJB Hunter, ... Analytical Chemistry 93 (8), 3786-3793, 2021 | 7 | 2021 |
| Pharmacologic hyperstabilisation of the HIV-1 capsid lattice induces capsid failure KMR Faysal, JC Walsh, N Renner, CL Márquez, VB Shah, AJ Tuckwell, ... Elife 13, e83605, 2024 | 6 | 2024 |
| Gene expression analysis of a panel of cell lines that differentially restrict HIV-1 CA mutants infection in a cyclophilin a-dependent manner VB Shah, C Aiken PloS one 9 (3), e92724, 2014 | 6 | 2014 |
| Cell fractionation and quantitative analysis of HIV-1 reverse transcription in target cells VB Shah, C Aiken Bio-protocol 3 (20), e949-e949, 2013 | 1 | 2013 |
